Loading…

Discovery of novel sesquistilbene indanone analogues as potent anti-inflammatory agents

To develop novel anti-inflammatory agents with improved pharmaceutical profiles, twenty-eight novel sesquistilbene indanone analogues were synthesized and evaluated for anti-inflammatory activity using RAW264.7 cells. Among these compounds, compound 11k was found to be one of the most potent analogu...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry 2016-05, Vol.113, p.63-74
Main Authors: Tang, Mei-Lin, Zhong, Chen, Liu, Zheng-Yu, Peng, Peng, Liu, Xin-Hua, Sun, Xun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To develop novel anti-inflammatory agents with improved pharmaceutical profiles, twenty-eight novel sesquistilbene indanone analogues were synthesized and evaluated for anti-inflammatory activity using RAW264.7 cells. Among these compounds, compound 11k was found to be one of the most potent analogues in inhibiting NO production in LPS-stimulated RAW264.7 cells. Furthermore, it could also significantly suppress LPS-induced iNOS and COX-2 expression and NO production through TLR4/JNK/NF-κB signaling pathway in a concentration dependent manner. Sesquistilbene indanone analogue 11k was much more potent than resveratrol for its anti-inflammatory activity. It could also significantly suppress LPS-induced iNOS and COX-2 expression and NO production through TLR4/JNK/NF-κB signaling pathway in a concentration dependent manner. [Display omitted] •Compound 11k was more effective than resveratrol.•(±)-11k, (+)-11k and (−)-11k, do not have impacts on activity and toxicity.•(±)-11k could suppress iNOS, COX-2 expression and NO production.•The mechanism of (±)-11k was through TLR4/JNK/NF-κB signaling pathway.
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2016.02.021